22 jul, 2016 - The plot is located in the Spanish town of Lliçà de Vall, a future industrial park adjacent to the industrial park of Llevant of Parets del Vallès, where currently Grifols has production facilities
05 jul, 2016 - GammaSTAN®, Gamunex® / Gamunex-C®, HyperHEP B®, HyperRAB®, HyperRHO®, HyperTET®, Koāte® DVI, Plasbumin®, Prolastin® / Prolastin® C and Thrombate® III are the newly added products
29 feb, 2016 - Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS) reported net revenues of Euros 3,934.6 million for 2015, growing +17.3% compared to Euros 3,355.4 million reported in 2014. Exchange rates movements, in particular of the US Dollar, had a positive impact on revenues; that grew +2.5% at constant currency (cc).
26 jan, 2016 - AlbaJuna Therapeutics, a spin-off from the IrsiCaixa AIDS Research Institute, is developing a new treatment strategy based on monoclonal antibodies with great potential to neutralize HIV and activate the "natural killer" cells responsible for destroying cells infected by the virus
08 jan, 2016 - Almost all cases of tetanus in the U.S. occur in people who have never been immunized or who have not had a tetanus booster shot within the preceding 10 years
14 dec, 2015 - From 1 January 2017 Victor Grifols Roura will be succeeded by his brother, Raimon Grifols, and his son, Víctor Grifols Deu, who will become joint and several chief executive officers of the company. Víctor Grifols will continue holding his position as non-executive chairman of the board of directors
07 dec, 2015 - The results may have implications in the choice of products for management in previously untreated patients (PUPs) with severe hemophilia A